About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Regulatory and Clinical

Catalyst Category

Regulatory and Clinical

Live feed of every catalyst classified under Regulatory and Clinical.

CATALYSTS IN FEED

168

AVG MAX MOVE

+116.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

DSMB Efficacy Met FDA 510(k) Cleared FDA Approval FDA Fast Track FDA Meeting FDA Meeting Granted Generic Drug Approved Inconclusive Topline Results IND Cleared for Study IND Filed NDA Resubmission Orphan Drug Designation Positive Subgroup Data Positive Topline Results Primary Endpoint Met SPA Agreement Study Complete Trial Enrollment Complete

Range–Clear

1 catalyst

Regulatory and ClinicalPositive Subgroup DataSep 21, 2026 · 4:05am ET

CUECue Biopharma, Inc.

Cue Biopharma Reports 60% Complete Hives Resolution for CUE-221 in Phase 2 Study

Post hoc analysis shows improvement over Omalizumab.

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+43.2%

RVOL

1.2x

Max high

$65.24

Fuel

1h 8m

Regulatory and ClinicalPositive Subgroup DataSep 21, 2026 · 4:05am ET

CUECue Biopharma, Inc.+43.2%

Cue Biopharma Reports 60% Complete Hives Resolution for CUE-221 in Phase 2 Study

RVOL

1.2x

Max high

$65.24

Fuel

1h 8m